Acquired phimosis is a documented postoperative complication following inflatable penile prosthesis (IPP) implantation. It occurs in uncircumcised men and consists of the development or progression of a non-retractable foreskin after surgery, regardless of preoperative status. Manufacturer documentation for devices such as Coloplast Titan IPP and AMS (Boston Scientific) explicitly lists acquired phimosis (or inability to retract the foreskin, or narrowing of the preputial opening) among recognized adverse events. These documents note that such events may necessitate subsequent surgery, which may or may not fully correct the issue.
The complication stems from surgical trauma and postoperative tissue response rather than direct mechanical interaction with the prosthesis cylinders or pump. It differs from congenital phimosis or primary balanitis xerotica obliterans (BXO)-related phimosis.
Pathophysiology and Mechanisms
- Postoperative edema and secondary lymphedema: Surgical dissection (particularly infrapubic or subcoronal approaches) disrupts lymphatic drainage in the penile skin and dartos. Fluid accumulates in the dependent foreskin, producing thickening and non-retractability. Prolonged edema promotes fibrosis at the preputial ring, converting transient swelling into cicatricial phimosis.
- Inflammatory and fibrotic healing: Cytokine-mediated scarring follows tissue handling, corporal dilation, and cylinder insertion. Subcoronal incisions with degloving increase distal edema and foreskin involvement.
- Mechanical and secondary factors: Early device inflation, sexual activity, or hygiene impairment during the edematous phase can exacerbate microtrauma, balanoposthitis, or scarring.
- Lymphatic interruption: Infrapubic access may transect superficial penile lymphatics more readily than penoscrotal.
Risk Factors
Risk is confined to uncircumcised patients. Preoperative foreskin assessment is standard; tight or non-retractable prepuce, history of recurrent balanitis, diabetes, obesity, smoking, prior penile surgery, radiation, or Peyronie’s disease elevate likelihood. Subcoronal approaches and extensive degloving further increase distal tissue reaction.
Incidence
Incidence data remain limited. Large registries and reviews of IPP complications (infection, mechanical failure, erosion, hematoma, glans ischemia) do not isolate acquired phimosis among primary endpoints, indicating it is not among the most frequent events. Case series document occurrences linked to persistent foreskin edema, with some progressing to require intervention. Manufacturer safety information includes it without frequency estimates, alongside other events that can produce permanent tissue changes or need revision.
Clinical Presentation
Clinical features appear between postoperative days 7–14, coinciding with peak swelling:
- Complete inability to retract the foreskin over the glans, with or without pain on attempted retraction.
- Foreskin ballooning on voiding, tightness, or “trapping” sensation.
- Local discomfort, pruritus, or pain during device cycling or erections.
- Smegma accumulation, odor, erythema, discharge, or recurrent balanoposthitis.
- Potential progression to paraphimosis (trapped retracted foreskin), urinary stream alteration, or mechanical interference with prosthesis function or sexual activity.
Diagnosis
Diagnosis is clinical. Physical examination reveals non-retractable, edematous or fibrotic prepuce. Infection must be excluded (fever, purulence, systemic signs). Device-related problems (erosion, floppy glans) are differentiated by history and exam.
Prevention
Prevention measures focus on preoperative identification and technical choices:
- Assessment of foreskin retractability in all uncircumcised candidates.
- Staged circumcision (6–12 weeks prior) or concomitant circumcision when indicated by tightness, balanitis history, or diabetes.
- Avoidance of unnecessary degloving in subcoronal approaches.
- Meticulous hemostasis, lymphatic preservation where possible, and antibiotic-coated devices with no-touch or modified sterile techniques.
- Postoperative protocols: compression, elevation, delayed cycling (4–6 weeks), and hygiene instructions (without early forceful retraction).
Management
Management options include:
- Conservative measures: oral corticosteroids or topical steroid application to address edema and inflammation; NSAIDs; compression and elevation; antibiotics for secondary infection. These may be trialed in the acute edematous phase.
- Surgical intervention: dorsal slit/preputioplasty for focal ring stenosis while attempting foreskin preservation, or circumcision for persistent cicatricial phimosis. These procedures are performed after initial healing (typically ≥3 months post-IPP to minimize implant-related risks). Extensive scarring may require skin grafting or more complex reconstruction.
Consequences if Untreated or Persistent
Untreated or persistent acquired phimosis produces ongoing hygiene difficulties, recurrent balanoposthitis, discomfort with device use or intercourse, urinary symptoms, and potential secondary infection that can involve the prosthesis.
